SlideShare a Scribd company logo
1 of 1
Download to read offline
Modeling the Process of T Cell Differentiation
Ousmane Mbaye1, 2
1Department of Electrical & Computer Engineering, College of Engineering, University of Massachusetts, Amherst,
MA 01003
E-mail: ombaye@student.umass.edu
2Department of Computational and Systems Biology, School of Medicine, University of Pittsburgh, Pittsburgh,
PA 15260
Abstract
T cells play an important role in an adaptive immune
response. Thus, understanding the process through
which they differentiate from naïve to effector cells
is valuable. In this project, we use NetLogo to build
an agent based model (ABM) in order to capture the
dynamics of T cell survival, differentiation, growth,
proliferation, and death. We start with a population
of naïve cells which are stimulated by their specific
antigens. Then, these activated cells express the
growth factor known as interleukin-2 (IL-2) and a
part of the high-affinity IL-2 receptor, known as
CD25, which allow them to bind with the IL-2
molecules present in the environment. After a
sufficient number of bonds, T cells proliferate and
differentiate into active effector cells, which can act
upon their target cells. An ABM allows for better
understanding of the T cell dynamics and it can be
used as a substitute for experimentation.
Introduction / Background
The purpose of this project is to use a computer
program to simulate T cells differentiation. To
achieve that goal T cells are modeled as mobile
agents interacting between them and with their
environment filled with antigen and IL-2. During the
process toward differentiation, T cells change their
behaviors and go through different states which
are:
 Motion
 Survival
 Death
 Growth
 Proliferation
 Differentiation
Using the agent based modeling environment
NetLogo, each state is implemented as a procedure
which is run by a main procedure at the start of the
simulation.
Methods
Results
1. Setup
The simulation takes place into the world which is
divided up into a grid of patches of equal size.
Each patch is a square of size 10 pixels. At start
up antigens (Ag) and naïve cells are randomly
distributed on patches.
 Round blue agents represent naïve cells
 Yellow patches contain antigens
 White patches do not contain antigens
2. Motion, Activation, and IL-2 Secretion
 Cells move around the world
 Simultaneous presence of antigen and a cell in a
patch is sufficient for cell activation
 The number of times a cell encounters antigens
determines its fate: inactive, TH, or Treg
 Red agents represent TH cells producing IL-2
 Green agents represent Treg cells
3. Growth, Proliferation, and Differentiation
 Activated cells express high affinity IL-2
receptors
 IL-2 receptors bind IL-2 molecules
 When the number of bonds is above a given
threshold, cells proliferate and differentiate into
effector cells
 Cells grow, proliferate, and differentiate into
effector cells: blue = Th and green = Treg
Number of Effector T cells over Time
 Antigen density on patches: 60%
 Number of naïve cells at start up: 200
 Threshold of bonds between IL-2 and its
receptors : 25, 000
 Number of TH cells 48 hours after
stimulation: 556
 Number of Treg cells 48 hours after
stimulation : 183
 Total number of effector cells: 739
Conclusion
 The simulation captures the fact that the doubling
time for T cells is between 24 and 36 hours on
average.
 A better understanding of the biology- IL-2
production and uptake; factors that drive T cells
toward the Th or Treg type- will improve the
predictions of the model.
 In NetLogo the world contains a limited number of
patches: this is a limiting factor for modeling a very
important cell population or a long simulation;
decreasing the patches’ size can increase their
number, but in that case the cells are so small that
they become very difficult to see.
Acknowledgments
 Professor James R. Faeder: Department of
Computational and Systems Biology, School of Medicine,
University of Pittsburgh, PA
 Dr. Natasa Miskov‐Zivanov: Department of Computational
and Systems Biology, School of Medicine, University of
Pittsburgh, PA
 Professor Penelope A. Morel: Department of Immunology,
School of Medicine, University of Pittsburgh, PA
 Professor Robert Parker: Department of Chemical and
Petroleum Engineering, University of Pittsburgh, PA
References
1. Busse et al. Competing feedback loops shape
IL-2 signaling between helper and regulatory T
lymphocytes in cellular microenvironments.
PNAS [Online] 2010.
2. Murphy, K.; Travers, P.; Walport, M. Janeway’s
Immunobiology, 7th ed.; Garland Science:
New York and London, 2008; pp 1-38; pp343-
350.
The 2012 Systems Medicine REU Program at Pittsburgh University is supported by the
National Science Foundation under Grant NSF EEC #1156889

More Related Content

What's hot

Monoclonal antibody production
Monoclonal antibody productionMonoclonal antibody production
Monoclonal antibody productionSrilaxmiMenon
 
MONOCLONAL ANTIBODY PRODUCTION STRATEGY
MONOCLONAL ANTIBODY PRODUCTION STRATEGYMONOCLONAL ANTIBODY PRODUCTION STRATEGY
MONOCLONAL ANTIBODY PRODUCTION STRATEGYAsh Hassan
 
Brian schaefer-scientia
Brian schaefer-scientiaBrian schaefer-scientia
Brian schaefer-scientiaBrianCSchaefer
 
Epitope mapping through bioinformatical analysis
Epitope mapping through bioinformatical analysisEpitope mapping through bioinformatical analysis
Epitope mapping through bioinformatical analysisJajati Keshari Nayak
 
Immunotolerance: mechanism and consequence
Immunotolerance: mechanism and consequence Immunotolerance: mechanism and consequence
Immunotolerance: mechanism and consequence Dr Alok Tripathi
 
T6α EFFECTOR FUNCTIONS AND MEMORY RESPONSE
T6α EFFECTOR FUNCTIONS AND MEMORY RESPONSET6α EFFECTOR FUNCTIONS AND MEMORY RESPONSE
T6α EFFECTOR FUNCTIONS AND MEMORY RESPONSEJeremy Brassard
 
Applications of Biotechnology in Animal Health
             Applications of Biotechnology in Animal Health             Applications of Biotechnology in Animal Health
Applications of Biotechnology in Animal HealthRajashekar Baldhu
 
Albert pujol reingeneering the human biology
Albert pujol   reingeneering the human biologyAlbert pujol   reingeneering the human biology
Albert pujol reingeneering the human biologyAlbert Pujol Torras
 
Difference between humoral and cell mediated immunity Dr. ihsan edan abdulkar...
Difference between humoral and cell mediated immunity Dr. ihsan edan abdulkar...Difference between humoral and cell mediated immunity Dr. ihsan edan abdulkar...
Difference between humoral and cell mediated immunity Dr. ihsan edan abdulkar...dr.Ihsan alsaimary
 
Hybridoma technology
Hybridoma technologyHybridoma technology
Hybridoma technologyilo0lo0
 
Innate-Like lymphocyte ILL (Unconventional lymphocytes)
Innate-Like lymphocyte ILL (Unconventional lymphocytes)Innate-Like lymphocyte ILL (Unconventional lymphocytes)
Innate-Like lymphocyte ILL (Unconventional lymphocytes)Ahmed Al-Abadlah
 
Navigation Control and Path Mapping of a Mobile Robot using Artificial Immune...
Navigation Control and Path Mapping of a Mobile Robot using Artificial Immune...Navigation Control and Path Mapping of a Mobile Robot using Artificial Immune...
Navigation Control and Path Mapping of a Mobile Robot using Artificial Immune...Waqas Tariq
 
Hybridoma technology
Hybridoma technologyHybridoma technology
Hybridoma technologyArchanaSoni3
 
Hybridoma technology
Hybridoma technologyHybridoma technology
Hybridoma technologyRitesh ranjan
 
Curing AIDS, with programming
Curing AIDS, with programmingCuring AIDS, with programming
Curing AIDS, with programmingAndrew Grimm
 
Monoclonal Antibody production
Monoclonal Antibody productionMonoclonal Antibody production
Monoclonal Antibody productionmammishobest
 

What's hot (20)

Monoclonal antibody production
Monoclonal antibody productionMonoclonal antibody production
Monoclonal antibody production
 
MONOCLONAL ANTIBODY PRODUCTION STRATEGY
MONOCLONAL ANTIBODY PRODUCTION STRATEGYMONOCLONAL ANTIBODY PRODUCTION STRATEGY
MONOCLONAL ANTIBODY PRODUCTION STRATEGY
 
Brian schaefer-scientia
Brian schaefer-scientiaBrian schaefer-scientia
Brian schaefer-scientia
 
Transplantation immunology part 1
Transplantation immunology part 1Transplantation immunology part 1
Transplantation immunology part 1
 
Epitope mapping through bioinformatical analysis
Epitope mapping through bioinformatical analysisEpitope mapping through bioinformatical analysis
Epitope mapping through bioinformatical analysis
 
Immunotolerance: mechanism and consequence
Immunotolerance: mechanism and consequence Immunotolerance: mechanism and consequence
Immunotolerance: mechanism and consequence
 
Monoclonal Antibody
Monoclonal AntibodyMonoclonal Antibody
Monoclonal Antibody
 
T6α EFFECTOR FUNCTIONS AND MEMORY RESPONSE
T6α EFFECTOR FUNCTIONS AND MEMORY RESPONSET6α EFFECTOR FUNCTIONS AND MEMORY RESPONSE
T6α EFFECTOR FUNCTIONS AND MEMORY RESPONSE
 
Lary nel abao cancer immunology report
Lary nel abao cancer immunology reportLary nel abao cancer immunology report
Lary nel abao cancer immunology report
 
Applications of Biotechnology in Animal Health
             Applications of Biotechnology in Animal Health             Applications of Biotechnology in Animal Health
Applications of Biotechnology in Animal Health
 
Albert pujol reingeneering the human biology
Albert pujol   reingeneering the human biologyAlbert pujol   reingeneering the human biology
Albert pujol reingeneering the human biology
 
Difference between humoral and cell mediated immunity Dr. ihsan edan abdulkar...
Difference between humoral and cell mediated immunity Dr. ihsan edan abdulkar...Difference between humoral and cell mediated immunity Dr. ihsan edan abdulkar...
Difference between humoral and cell mediated immunity Dr. ihsan edan abdulkar...
 
Hybridoma technology
Hybridoma technologyHybridoma technology
Hybridoma technology
 
Innate-Like lymphocyte ILL (Unconventional lymphocytes)
Innate-Like lymphocyte ILL (Unconventional lymphocytes)Innate-Like lymphocyte ILL (Unconventional lymphocytes)
Innate-Like lymphocyte ILL (Unconventional lymphocytes)
 
Navigation Control and Path Mapping of a Mobile Robot using Artificial Immune...
Navigation Control and Path Mapping of a Mobile Robot using Artificial Immune...Navigation Control and Path Mapping of a Mobile Robot using Artificial Immune...
Navigation Control and Path Mapping of a Mobile Robot using Artificial Immune...
 
Hybridoma technology
Hybridoma technologyHybridoma technology
Hybridoma technology
 
Gene therapy
Gene therapyGene therapy
Gene therapy
 
Hybridoma technology
Hybridoma technologyHybridoma technology
Hybridoma technology
 
Curing AIDS, with programming
Curing AIDS, with programmingCuring AIDS, with programming
Curing AIDS, with programming
 
Monoclonal Antibody production
Monoclonal Antibody productionMonoclonal Antibody production
Monoclonal Antibody production
 

Similar to pittREUposter_OM

Endothelial Cell Mediated Delay of Blood Brain Barrier Recovery Following Tra...
Endothelial Cell Mediated Delay of Blood Brain Barrier Recovery Following Tra...Endothelial Cell Mediated Delay of Blood Brain Barrier Recovery Following Tra...
Endothelial Cell Mediated Delay of Blood Brain Barrier Recovery Following Tra...Arthur Stem
 
1. Development of immunity_MWM.pdf
1. Development of immunity_MWM.pdf1. Development of immunity_MWM.pdf
1. Development of immunity_MWM.pdfNayeemulIslam13
 
Paracrine TGF_IL2 paper
Paracrine TGF_IL2 paperParacrine TGF_IL2 paper
Paracrine TGF_IL2 paperMichael McHugh
 
cdc42J Exp Med-2010-Pulecio-2719-32
cdc42J Exp Med-2010-Pulecio-2719-32cdc42J Exp Med-2010-Pulecio-2719-32
cdc42J Exp Med-2010-Pulecio-2719-32Federica Benvenuti
 
Age dependent changes in the human t-cell repertoire
Age dependent changes in the human t-cell repertoireAge dependent changes in the human t-cell repertoire
Age dependent changes in the human t-cell repertoireeman youssif
 
Pharm immuno2 cells of the immune system
Pharm immuno2 cells of the immune systemPharm immuno2 cells of the immune system
Pharm immuno2 cells of the immune systemmmoney1
 
T CELL INTERACTINS WITH PERIODNTAL DISEASES
T CELL INTERACTINS WITH PERIODNTAL DISEASES T CELL INTERACTINS WITH PERIODNTAL DISEASES
T CELL INTERACTINS WITH PERIODNTAL DISEASES Dr. Saurabh Jain
 
Cells of immune response
Cells of immune responseCells of immune response
Cells of immune responseEsraa Gamal
 
Essay Writing Services Australia
Essay Writing Services AustraliaEssay Writing Services Australia
Essay Writing Services Australia#essaywriting
 
Analysis of Human Embryonic Stem Cells with Regulatable Expression of the Cel...
Analysis of Human Embryonic Stem Cells with Regulatable Expression of the Cel...Analysis of Human Embryonic Stem Cells with Regulatable Expression of the Cel...
Analysis of Human Embryonic Stem Cells with Regulatable Expression of the Cel...Christopher S Park
 

Similar to pittREUposter_OM (20)

IsoPlexis Trifold
IsoPlexis TrifoldIsoPlexis Trifold
IsoPlexis Trifold
 
Endothelial Cell Mediated Delay of Blood Brain Barrier Recovery Following Tra...
Endothelial Cell Mediated Delay of Blood Brain Barrier Recovery Following Tra...Endothelial Cell Mediated Delay of Blood Brain Barrier Recovery Following Tra...
Endothelial Cell Mediated Delay of Blood Brain Barrier Recovery Following Tra...
 
HLA-DRB1
HLA-DRB1HLA-DRB1
HLA-DRB1
 
1. Development of immunity_MWM.pdf
1. Development of immunity_MWM.pdf1. Development of immunity_MWM.pdf
1. Development of immunity_MWM.pdf
 
Paracrine TGF_IL2 paper
Paracrine TGF_IL2 paperParacrine TGF_IL2 paper
Paracrine TGF_IL2 paper
 
T regulatory cell
T regulatory cellT regulatory cell
T regulatory cell
 
1
11
1
 
cdc42J Exp Med-2010-Pulecio-2719-32
cdc42J Exp Med-2010-Pulecio-2719-32cdc42J Exp Med-2010-Pulecio-2719-32
cdc42J Exp Med-2010-Pulecio-2719-32
 
Immunology
ImmunologyImmunology
Immunology
 
Age dependent changes in the human t-cell repertoire
Age dependent changes in the human t-cell repertoireAge dependent changes in the human t-cell repertoire
Age dependent changes in the human t-cell repertoire
 
Déjà vu blame it on the tregs
Déjà vu blame it on the tregsDéjà vu blame it on the tregs
Déjà vu blame it on the tregs
 
Immunology
ImmunologyImmunology
Immunology
 
Flow cytometry
Flow cytometryFlow cytometry
Flow cytometry
 
Adaptive immune system.docx
Adaptive immune system.docxAdaptive immune system.docx
Adaptive immune system.docx
 
Pharm immuno2 cells of the immune system
Pharm immuno2 cells of the immune systemPharm immuno2 cells of the immune system
Pharm immuno2 cells of the immune system
 
T CELL INTERACTINS WITH PERIODNTAL DISEASES
T CELL INTERACTINS WITH PERIODNTAL DISEASES T CELL INTERACTINS WITH PERIODNTAL DISEASES
T CELL INTERACTINS WITH PERIODNTAL DISEASES
 
Organs of immune system
Organs of immune systemOrgans of immune system
Organs of immune system
 
Cells of immune response
Cells of immune responseCells of immune response
Cells of immune response
 
Essay Writing Services Australia
Essay Writing Services AustraliaEssay Writing Services Australia
Essay Writing Services Australia
 
Analysis of Human Embryonic Stem Cells with Regulatable Expression of the Cel...
Analysis of Human Embryonic Stem Cells with Regulatable Expression of the Cel...Analysis of Human Embryonic Stem Cells with Regulatable Expression of the Cel...
Analysis of Human Embryonic Stem Cells with Regulatable Expression of the Cel...
 

pittREUposter_OM

  • 1. Modeling the Process of T Cell Differentiation Ousmane Mbaye1, 2 1Department of Electrical & Computer Engineering, College of Engineering, University of Massachusetts, Amherst, MA 01003 E-mail: ombaye@student.umass.edu 2Department of Computational and Systems Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15260 Abstract T cells play an important role in an adaptive immune response. Thus, understanding the process through which they differentiate from naïve to effector cells is valuable. In this project, we use NetLogo to build an agent based model (ABM) in order to capture the dynamics of T cell survival, differentiation, growth, proliferation, and death. We start with a population of naïve cells which are stimulated by their specific antigens. Then, these activated cells express the growth factor known as interleukin-2 (IL-2) and a part of the high-affinity IL-2 receptor, known as CD25, which allow them to bind with the IL-2 molecules present in the environment. After a sufficient number of bonds, T cells proliferate and differentiate into active effector cells, which can act upon their target cells. An ABM allows for better understanding of the T cell dynamics and it can be used as a substitute for experimentation. Introduction / Background The purpose of this project is to use a computer program to simulate T cells differentiation. To achieve that goal T cells are modeled as mobile agents interacting between them and with their environment filled with antigen and IL-2. During the process toward differentiation, T cells change their behaviors and go through different states which are:  Motion  Survival  Death  Growth  Proliferation  Differentiation Using the agent based modeling environment NetLogo, each state is implemented as a procedure which is run by a main procedure at the start of the simulation. Methods Results 1. Setup The simulation takes place into the world which is divided up into a grid of patches of equal size. Each patch is a square of size 10 pixels. At start up antigens (Ag) and naïve cells are randomly distributed on patches.  Round blue agents represent naïve cells  Yellow patches contain antigens  White patches do not contain antigens 2. Motion, Activation, and IL-2 Secretion  Cells move around the world  Simultaneous presence of antigen and a cell in a patch is sufficient for cell activation  The number of times a cell encounters antigens determines its fate: inactive, TH, or Treg  Red agents represent TH cells producing IL-2  Green agents represent Treg cells 3. Growth, Proliferation, and Differentiation  Activated cells express high affinity IL-2 receptors  IL-2 receptors bind IL-2 molecules  When the number of bonds is above a given threshold, cells proliferate and differentiate into effector cells  Cells grow, proliferate, and differentiate into effector cells: blue = Th and green = Treg Number of Effector T cells over Time  Antigen density on patches: 60%  Number of naïve cells at start up: 200  Threshold of bonds between IL-2 and its receptors : 25, 000  Number of TH cells 48 hours after stimulation: 556  Number of Treg cells 48 hours after stimulation : 183  Total number of effector cells: 739 Conclusion  The simulation captures the fact that the doubling time for T cells is between 24 and 36 hours on average.  A better understanding of the biology- IL-2 production and uptake; factors that drive T cells toward the Th or Treg type- will improve the predictions of the model.  In NetLogo the world contains a limited number of patches: this is a limiting factor for modeling a very important cell population or a long simulation; decreasing the patches’ size can increase their number, but in that case the cells are so small that they become very difficult to see. Acknowledgments  Professor James R. Faeder: Department of Computational and Systems Biology, School of Medicine, University of Pittsburgh, PA  Dr. Natasa Miskov‐Zivanov: Department of Computational and Systems Biology, School of Medicine, University of Pittsburgh, PA  Professor Penelope A. Morel: Department of Immunology, School of Medicine, University of Pittsburgh, PA  Professor Robert Parker: Department of Chemical and Petroleum Engineering, University of Pittsburgh, PA References 1. Busse et al. Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironments. PNAS [Online] 2010. 2. Murphy, K.; Travers, P.; Walport, M. Janeway’s Immunobiology, 7th ed.; Garland Science: New York and London, 2008; pp 1-38; pp343- 350. The 2012 Systems Medicine REU Program at Pittsburgh University is supported by the National Science Foundation under Grant NSF EEC #1156889